Taiko Pharmaceutical Co.,Ltd.

TSE:4574.T

378 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q12020 Q32020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q1
Operating Activities:
Net Income -271-243-1,713-384-1,050-1,748-7,647425-1479883271,48553810312983841038-5987717799-202997289-35666517350-341,102431271-171802587529-210788294165-220297-1,377.213-179.209-196.272-243.198-423.4171,209.0531,080.949722.92182.758
Depreciation & Amortization 0000000000000000000000000000000000000000000065.32362.55758.54554.83962.39556.00449.58544.2351.917
Deferred Income Tax 00000000000000000000000000000000000000000000000000000
Stock Based Compensation 00000000000000000000000000000000000000000000000000000
Change In Working Capital 000000000000000000000000000000000000000000001,120.08689.244-541.418-327.3951,304.864149.186-921.369-1,215.935962.973
Accounts Receivables 00000000000000000000000000000000000000000000000000000
Change In Inventory 00000000000000000000000000000000000000000000106.469127.324-15.129-109.179-154.683-431.12-117.41735.057-202.302
Change In Accounts Payables 00000000000000000000000000000000000000000000000000000
Other Working Capital 000000000000000000000000000000000000000000001,013.617-38.08-526.289-218.2161,459.547580.306-803.952-1,250.9921,165.275
Other Non Cash Items 2712431,7133841,0501,7487,647-425147-988-327-1,485-538-103-129-838-410-3859-877-177-99202-997-28935-66-651-73-5034-1,102-431-271171-802-587-529210-788-294-165220-297592.726-40.65575.871-904.065-18.689-178.813101.956-126.679129.937
Operating Cash Flow 00000000000000000000000000000000000000000000400.922-68.063-603.274-1,419.819925.1531,235.43311.121-575.4631,227.585
Investing Activities:
Investments In Property Plant And Equipment 00000000000000000000000000000000000000000000-24.328-134.937-22.232-16.445-28.575-97.241-87.56-11.721-27.134
Acquisitions Net 00000000000000000000000000000000000000000000000033.3010000
Purchases Of Investments 000000000000000000000000000000000000000000000-0.1-0.41-0.3-0.299-0.394-0.386-0.3-0.299
Sales Maturities Of Investments 000000000000000000000000000000000000000000000000193.1960000
Other Investing Activites 00000000000000000000000000000000000000000000971.157-87.892142.9021.099-56.73723.276-54.1119.88-18.278
Investing Cash Flow 00000000000000000000000000000000000000000000942.959-219.059120.26-15.64674.284-41.058-142.057-2.141-55.806
Financing Activities:
Debt Repayment 00000000000000000000000000000000000000000000000-3.95100000
Common Stock Issued 000000000000000000000000000000000000000000001.24549.8249.34221.17500000
Common Stock Repurchased 00000000000000000000000000000000000000000000000-0.01600000
Dividends Paid 00000000000000000000000000000000000000000000-0.101-0.234-29.681-96.108000-21.260
Other Financing Activities 00000000000000000000000000000000000000000000-4.302-4.314-4.427-3.952000-2.4140
Financing Cash Flow 00000000000000000000000000000000000000000000-3.15845.276-24.766-78.901-4.253-3.048-2.556-23.674-2.425
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000000000000000000000000-5.94-25.488-32.8215.60310.907-23.597-3.31123.912-42.91
Net Change In Cash 000000000000000000000000000000000000000000001,334.785-267.334-540.602-1,508.7641,006.0921,167.728163.196-577.3661,126.446
Cash At End Of Period 000000000000000000000000000000000000000000004,073.492,738.7053,006.0393,546.6415,055.4054,049.3132,881.5852,718.3893,295.755